MedPath

Feasibility, Acceptability and Fidelity of Integrating a Navigation Intervention Into Tobacco Treatment Program

Not Applicable
Completed
Conditions
Cancer
Registration Number
NCT07072312
Lead Sponsor
Fox Chase Cancer Center
Brief Summary

Patient Navigation is being included as part of a tobacco treatment program for cancer patients to help patients overcome barriers to quitting.

Detailed Description

The primary objective of this prospective, interventional pilot study is to assess the feasibility, acceptability and fidelity of a navigation intervention embedded into the clinical Tobacco Treatment Program.

The investigators will employ a pre-post design with two cohorts (30 to the pre-intervention, and 90 to the intervention, respectively) to address the specific aims of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
93
Inclusion Criteria
  1. Patients with a cancer diagnosis. Patients may be undergoing active therapy or may have completed treatment.
  2. English speaking.
  3. Age > 18 years.
  4. Active tobacco cigarette user, defined as having smoked a cigarette within the 30 days prior to enrollment.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Feasibility of Integrating Navigation into Tobacco Treatment ProgramPrior to first TTP visit - consented and enrolled

The number of patients who enroll and consent to receiving the tobacco treatment program navigation intervention. Feasibility will be obtained if at least 60% consent and enroll.

Patient Acceptability of Navigation in Tobacco Treatment - Patient RecommendationOne and six months post initial navigation intervention

The number of patients who state they would likely or highly likely to recommend the service to other cancer patients. Acceptability will obtained if 70% of patients likely recommend the service.

Provider Implementation of the Intervention -Fidelity to ProtocolBaseline to 6 months

The number of patients who receive the two primary components of the navigation intervention, assessing tobacco cessation barriers and psychosocial barriers. Fidelity will be achieved if 80% of cases include both elements measured through a review of the navigation case management system.

Fidelity of Utilization of Navigation Intervention - Patient ParticipationBaseline to 6 months

Number of patients who had at least 2 navigation encounters. Fidelity will be achieved if 80% of patients have a minimum of 2 navigation encounters through the navigation case management review.

Secondary Outcome Measures
NameTimeMethod
7-Day Point PrevalenceSix months

7-Day point prevalence of tobacco will be assessed at six month follow up.

Trial Locations

Locations (1)

Fox Chase Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.